Impact of the microbiome on checkpoint inhibitor treatment in patients with non-small cell lung cancer and melanoma

The microbiome is increasingly recognized for its role in multiple aspects of cancer development and treatment, specifically in response to checkpoint inhibitors. While checkpoint inhibitors have revolutionized cancer treatment by producing durable anti-tumor responses, only a minority of patients r...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaikh, Fyza Y., Gills, Joell J., Sears, Cynthia L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838599/
https://www.ncbi.nlm.nih.gov/pubmed/31597596
http://dx.doi.org/10.1016/j.ebiom.2019.08.076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838599/
https://www.ncbi.nlm.nih.gov/pubmed/31597596
http://dx.doi.org/10.1016/j.ebiom.2019.08.076

Ejemplares similares